Company profile
Verrica Pharmaceuticals Inc. insider acquisitions
Company CIK 0001660334 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
13 dated transactions · 5 of 5 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Dec 23, 2025 | Verrica Pharmaceuticals Inc.Common Stock | Kirby John J. | Stock award |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Series C Warrant (right to buy) | Zawitz David | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Common Stock | Zawitz David | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Series C Warrant (right to buy) | Rieger Jayson | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Common Stock | Rieger Jayson | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Series C Warrant (right to buy) | Rosenberg Noah L. | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Common Stock | Rosenberg Noah L. | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Series C Warrant (right to buy) | Kirby John J. | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Common Stock | Kirby John J. | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Series C Warrant (right to buy) | Manning Paul B | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Series C Warrant (right to buy) | Manning Paul B | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Common Stock | Manning Paul B | Purchase |
| Nov 25, 2025 | Verrica Pharmaceuticals Inc.Common Stock | Manning Paul B | Purchase |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
VRCA · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Kirby John J.Interim CFO | Stock awardCommon StockNon-derivative security · Code A | 10,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Zawitz DavidChief Operating Officer | PurchaseSeries C Warrant (right to buy)Derivative security · Code P | 2,500 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Zawitz DavidChief Operating Officer | PurchaseCommon StockNon-derivative security · Code P | 10,000 | 4.2425Value: 42,425Currency not specified | View ↗ |
| Trade: | Rieger JaysonCEO and President · Director | PurchaseSeries C Warrant (right to buy)Derivative security · Code P | 23,577 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Rieger JaysonCEO and President · Director | PurchaseCommon StockNon-derivative security · Code P | 94,311 | 4.2425Value: 400,114.4175Currency not specified | View ↗ |
| Trade: | PurchaseSeries C Warrant (right to buy)Derivative security · Code P | 589 | Not reported *Value: Not reportedCurrency not specified | View ↗ | |
| Trade: | PurchaseCommon StockNon-derivative security · Code P | 2,357 | 4.2425Value: 9,999.5725Currency not specified | View ↗ | |
| Trade: | Kirby John J.Interim CFO | PurchaseSeries C Warrant (right to buy)Derivative security · Code P | 884 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Kirby John J.Interim CFO | PurchaseCommon StockNon-derivative security · Code P | 3,536 | 4.2425Value: 15,001.48Currency not specified | View ↗ |
| Trade: | Manning Paul BDirector · 10% owner | PurchaseSeries C Warrant (right to buy)Derivative security · Code P | 687,690 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Manning Paul BDirector · 10% owner | PurchaseSeries C Warrant (right to buy)Derivative security · Code P | 343,845 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Manning Paul BDirector · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 2,750,762 | 4.2425Value: 11,670,107.785Currency not specified | View ↗ |
| Trade: | Manning Paul BDirector · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 1,375,380 | 4.2425Value: 5,835,049.65Currency not specified | View ↗ |
13 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →